Barrett & Company’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Barrett & Company's GSK Position: Q3 2026 in Review
Barrett & Company increased its GSK (GSK) stake by 0.29% in Q3 2026, buying an estimated $306 and bringing the position to 2,072 shares worth $100K. The position accounts for 0.03% of the portfolio, ranked #221.
Barrett & Company first reported a position in GSK in Q3 2022 and has held it in 17 quarters since. The position peaked at $289K in Q4 2022. 989 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Barrett & Company held 2,072 shares of GSK worth $100K as of Q3 2026.
- Barrett & Company bought 6 GSK shares in Q3 2026, an estimated $306.
- GSK made up 0.03% of Barrett & Company's portfolio in Q3 2026, its #221 holding.
- Barrett & Company first reported a position in GSK in Q3 2022 and has held it in 17 quarters since.
- Barrett & Company's GSK position peaked at $289K in Q4 2022.
- 989 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Barrett & Company's 13F filing for Q3 2026, filed 22 Oct 2026.